Summit Marks EU’s Commitment to Building an Age-friendly Europe by 2020

Official Event of Ireland’s EU Presidency Hosted by Global Coalition on Aging and Ageing Well Network Will Drive Policy and Innovation for an Aging Europe

DUBLIN (13 June 3013) – The EU Summit on Active and Healthy Aging, beginning today in Dublin, will tackle the challenge of population aging, one of the most pressing issues facing Europe – and the globe. It comes just one day after the death of the world’s oldest person underscoring that aging can be characterized by health, productivity and optimism.  Japan’s Jiroemon Kimura died yesterday of natural causes at the age of 116, having worked  beyond retirement age and into his 90s, highlighting the folly of keeping with a retirement concept invented in another century.

As Europe’s aging population has already begun to experience health, economic and fiscal strife, this unique Summit seeks to implement solutions that turn this challenge into an opportunity.

“Today’s aging challenge results from a shift in the proportion of old to young, creating a demographic make-up the world has never before experienced,” said Michael Hodin, PhD, Executive Director of the Global Coalition on Aging. “If left unaddressed, it will create a peculiar mismatch between 21st-century demographic realities and 20th-century public policy.  Yet those who meet the challenge with vision and innovation will be the winners in the 21st century’s competitiveness race.”

The majority of children born in Europe today will live to be at least 100 years old. Unless early action is taken, this rapidly increasing number of older people, exacerbated by plummeting birth rates, will be a huge burden on European finances. By bringing together global policymakers, business leaders, academics, economic experts and NGOs the Summit will explore ways to add two extra healthy years to people’s lives, ensuring that older people will be able to remain active and productive in society and in the workforce.

“To lead change for this demographic challenge in a sustainable way, we must create new competition, new jobs and incentives for new innovation,” said Esko Aho, Senior Fellow at Harvard University and former Prime Minister of Finland.  “From this Summit, we look to share not only good ideas, but also good execution.”

The centerpiece of the Summit is this evening’s signing of the 2013 Dublin Declaration on Age Friendly Cities and Communities by more than 50 mayors from across nearly 20 European countries. The ceremony will be led by the Lord Mayor of Dublin, Naoise Ó Muirí. As it will establish Europe-wide commitment to the age-friendly movement, it will also mark the official launch of Dublin city as an age-friendly city.

“The [aging] challenges can be overcome if we act now to ensure a joined-up approach,” said Máire Geoghegan-Quinn, EU Commissioner for Research, Innovation and Science. “An older population will create demand for new types of products and services, so businesses must prepare for this change….We must ensure that this issue remains a top priority for all policymakers throughout Europe,” she said.

Over two days, the Summit will explore aging through a life course approach to staying active and healthy. From rethinking the way we reach and plan for retirement to promoting the prevention of debilitating age-related skin conditions, and from reinventing the traditional view of senior care to investing in programs to fight the scourge of Alzheimer’s disease, the Summit will showcase some of the best innovations from across the globe and therefore lead to tangible solutions.

“Aging is an international challenge and that’s why it’s so important to develop a Europe-wide strategy,” said Anne Connolly, Director of the Ageing Well Network. “We’re very excited to host this Summit in Ireland, and I hope that this will be the start of a new thinking on aging throughout Europe,” she said.

Summit speakers include:

  • Esko Aho, Senior Fellow at Harvard University and former Prime Minister of Finland
  • John Beard, Director of the Department of Ageing and Life Course, World Health Organization
  • Máire Geoghegan-Quinn, EU Commissioner for Research, Innovation and Science
  • Baroness Sally Greengross, Member of the UK House of Lords and President of the International Longevity Centre UK
  • Phil Hogan, Ireland’s Minister for the Environment, Community and Local Government
  • Jeff Huber, President of Home Instead Senior Care
  • Marko Mrsnik, Director in the European Sovereign Ratings Group at Standard and Poor’s
  • David Ryan, Global Director of Health Business Innovation at Intel Corporation

The Summit is hosted by the Global Coalition on Aging, in partnership with Ireland’s Ageing Well Network and with the support of the European Innovation Partnership. It is an official event of Ireland’s EU Presidency.

For further information, see www.ahaconference2013.ie.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

GCOA Sign-on Letter to Governor Spanberger: Consequences of Importing Federal Price Caps on Virginians’ Access to Medicine & Healthy Aging Opportunities

Dear Governor Spanberger: We, the undersigned organizations, bring deep, on‑the‑ground experience serving older Americans, patients managing complex and chronic conditions, and their caregivers across Virginia and nationwide. We also have a clear understanding of which policies and programs are effective and where they fall short.

New Report Summarizes State of Expert Opinions on Japan’s Adult Vaccine Policy as Population Shifts Older

The Global Coalition on Aging (GCOA), Health and Global Policy Institute (HGPI), and the Asia-Pacific Consortium for Healthy Aging and Adult Immunization (AP-CHAAI) today announced the launch of Strengthening Vaccine Policy for Healthy Aging and Economic Growth in Japan, a landscape analysis examining the state of vaccine policy in super-aging Japan. Based on a comprehensive review of over 100 policy documents, recommendations, reports, academic papers, and gray literature articles, the report, which was funded by GSK, summarizes the latest academic research and policy discourse around adult vaccines.

WSJ Letter to the Editor: How Flu Vaccine Policies Affect the Economy

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will have negative consequences. Mr. Prasad’s decision to reject Moderna’s flu vaccine without even reviewing it is even worse than you describe. Denying us a new, innovative flu vaccine is horrible health policy. Innovation is at risk because, as Moderna’s CEO has said, if the largest market is off limits, investments won’t be made. But the decision will also have economic consequences. Investment in preventive health is critical as our population ages. In its April 2025 World Economic Outlook report, the International Monetary Fund dedicated an entire chapter to the need for healthier longevity as the global population ages.

Joe Biden’s ‘Cancer Moonshot’ May be Derailed by New Policies, Including His Own

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

Kishida and Biden Face a Similar Demographic Crisis

Your front page story “Japan wrestles with age-old problem as population declines at record rate” (Report, April 13) and the letter in the same edition from Tim Hill, “A gently declining population is no reason to panic”, both describe what all societies face as they modernise in the 21st century.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.